Synupse
Synupse develops an AI-powered, patient-centered Clinical Decision Support System (CDSS) for orthopedic and clinical practice, serving healthcare providers primarily in Iran through a hybrid physical-clinic and SaaS platform model.
- Company typePrivate
- Founded2010
- HeadquartersMadrid, Spain
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Synupse does
Synupse is a Tehran, Iran-based healthcare technology startup developing an AI-powered, patient-centered Clinical Decision-Making Support System (CDSS) targeted at orthopedic and broader clinical practice. The platform collects real-time patient data to generate personalized, condition- and lifestyle-specific treatment plans and to coordinate decision-making across multiple medical specialties. The product is grounded in a proprietary patient-centered methodology developed by founder Dr. Hamid Farrokhi, inspired by Cognitive Behavioral Therapy (CBT) methods from psychology and validated through operations at Sepid Orthopedic Clinic, which the same founder established in 2015-2016 as Iran's first patient-centered orthopedic practice.
The platform integrates recommendation and process-automation capabilities to classify diseases and propose treatment pathways based on patient history, examination checklists, lifestyle inputs, and clinical feedback. Synupse operates a hybrid physical-digital model in which Sepid Orthopedic Clinic functions simultaneously as a service provider, an internal deployment, and the primary R&D testing ground for new digital features before any broader commercial release. According to company-reported figures, more than 18,000 patients have been served and more than 7,000 orthopedic diseases studied through the combined platform-clinic operation.
Synupse is bootstrapped and founder-owned, with no disclosed external funding, institutional investors, or revenue figures. Its go-to-market is sales-led and direct, targeting healthcare providers and medical practices primarily in Iran, with marketing concentrated on its website, LinkedIn, and Instagram. Pricing is not publicly disclosed, and the SaaS product is described as being in MVP development as of mid-2022, indicating that commercial traction outside the affiliated clinic has not yet been established.
Synupse firmographics
Firmographics- Name
- Synupse
- Legal name
- Synupse
- Website
- https://synupse.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Synupse develops an AI-powered, patient-centered Clinical Decision Support System (CDSS) for orthopedic and clinical practice, serving healthcare providers primarily in Iran through a hybrid physical-clinic and SaaS platform model.
- Ownership category
- akta.pro rank
Synupse industry classification
Industry- Product category
- Healthcare Clinical Decision Support Software
- NAICS
- Other Computer Related Services (541519), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Utilization Management, Appropriateness Criteria & Prior Authorization CDS (HLACAGAM)
- akta.pro secondary industry
- AI Triage & Clinical Decision Support (CDS) Platforms (HLALAJAD)
Keywords
Where Synupse is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Synupse business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Clinical Decision Support System Platform: SaaS-based clinical decision support system provided to healthcare providers, functioning as both an electronic health system and innovation in medical care delivery.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Synupse product offering
Product offeringCore offering
Synupse develops and sells an AI-powered, patient-centered Clinical Decision-making Support System (CDSS) platform that collects real-time patient data, classifies disease and treatment plans based on patient condition and lifestyle, and enables collaborative decision-making across multiple medical specialties. The platform functions as both an electronic health system and a clinical decision support tool, with a hybrid physical-digital model anchored by the Sepid Orthopedic Clinic in Tehran, Iran, which serves as R&D testbed and reference customer. Target buyers are healthcare providers and medical practices seeking personalized, data-driven treatment planning.
Product overview
Synupse offers a single unified product — its AI-powered Clinical Decision-Making Support System (CDSS). The platform serves as a patient-centered solution that combines electronic health record capabilities with intelligent clinical decision support. The system records patient details, learns from patient and medical team data, and generates personalized treatment plans based on individual patient conditions and lifestyles. Patients are involved in every step of the treatment process, with the platform enabling collaborative decision-making across different medical specialties.
Differentiator
Problem solved
Functional benefit
Products and services
- Synupse Clinical Decision-Making Support System (CDSS) An AI-powered, patient-centered Clinical Decision-Making Support System that collects real-time patient data, classifies disease and treatment plans based on patient condition and lifestyle, and enables collaborative multi-specialty decision-making for healthcare providers. It functions both as an electronic health system and as a clinical decision support tool for personalized treatment planning.
Quantifiable outcome
- 18,000+ patients served through the platform and clinic
- +2 more outcomes
Companies that use Synupse
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
Synupse technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Synupse partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sepid Orthopedic CliniccoreSepid Orthopedic Clinic, founded by Synupse founder Dr. Hamid Farrokhi in 2016, operates as Iran's first patient-centered orthopedic practice. The clinic serves as Synupse's primary R&D testing ground, where ideas and hypotheses are tested in practical ways before becoming digital products. Sepid team members form a significant portion of Synupse's R&D development team, creating a tight integration between clinical practice and product development.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Synupse competitors and assessment
Company assessmentDirect peers
- Infermedica: Infermedica provides an AI-based symptom checker and triage/clinical decision support API used by health systems and insurers. It is a direct peer to Synupse because both deploy AI models to convert patient-reported data into clinical decision support outputs for healthcare stakeholders.
- Babylon Health: Babylon Health built AI-powered clinical decision support and triage tools integrated into telehealth and provider workflows. Synupse shares the AI-CDSS core function of guiding clinical decisions from patient inputs, though Babylon scaled via a global telehealth model rather than a specialty clinic model.
- Ada Health: Ada Health offers an AI-powered symptom assessment and clinical decision support platform used by patients and providers. It is directly comparable to Synupse as both build AI-driven CDS tools that translate patient inputs into structured clinical guidance, though Ada operates globally while Synupse is orthopedic-focused.
- Mediktor: Mediktor offers an AI-based pre-diagnosis and triage platform used by hospitals, insurers, and telehealth providers. It is comparable to Synupse as another AI-driven clinical decision support layer that takes patient symptom data and produces structured clinical recommendations.
Emerging players
- Qventus: Qventus applies AI to hospital operations and clinical workflows, including discharge planning and care pathway optimization. It overlaps with Synupse in using AI to support clinical and operational decision-making, though Qventus focuses on operational rather than treatment-planning decisions.
- Health Catalyst: Health Catalyst provides data, analytics, and decision-support infrastructure to health systems. It is a partial peer because both companies convert clinical and patient data into actionable decision support, though Health Catalyst is a horizontal data/analytics platform rather than a specialty CDSS product.
- LeanTaas: LeanTaas delivers AI-driven decision support for healthcare operations, including scheduling, capacity, and patient flow. It is an adjacent peer because both companies deploy AI to embed decision support into clinical workflows, though LeanTaas is operations-focused while Synupse is treatment-planning focused.
Broad incumbents
- K Health: K Health combines AI-driven clinical decision support with virtual primary care delivery, using patient data to generate treatment guidance. It overlaps with Synupse on the AI-CDSS layer but operates at a much broader primary-care scale and combines CDS with full telehealth services.
- Wolters Kluwer UpToDate: UpToDate is the dominant evidence-based clinical decision support reference used by hospitals and clinicians worldwide. It is a broad incumbent competitor to Synupse because it addresses the same physician need for point-of-care clinical guidance, though delivered as expert-authored reference content rather than AI-personalized recommendations.
- Elsevier ClinicalPath (formerly Via Oncology): Elsevier's ClinicalPath and related clinical decision support tools provide evidence-based care pathway guidance to providers. It is comparable to Synupse as another clinical decision support product aiming to standardize and personalize treatment planning across specialties, but at a far larger enterprise scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Synupse social profiles
Digital presenceSynupse financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synupse leadership team
Management profileNumber of profiles
Profiles5 records
Synupse subsidiaries and ownership
Company hierarchySubsidiaries1 record
Synupse funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synupse M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synupse
What does Synupse do?
Synupse develops and sells an AI-powered, patient-centered Clinical Decision-making Support System (CDSS) platform that collects real-time patient data, classifies disease and treatment plans based on patient condition and lifestyle, and enables collaborative decision-making across multiple medical specialties. The platform functions as both an electronic health system and a clinical decision support tool, with a hybrid physical-digital model anchored by the Sepid Orthopedic Clinic in Tehran, Iran, which serves as R&D testbed and reference customer. Target buyers are healthcare providers and medical practices seeking personalized, data-driven treatment planning.
Is Synupse a public or private company?
Synupse is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Synupse founded?
Synupse was founded in 2010. It employs 1 to 10 people.
Where is Synupse based?
Synupse is headquartered in Madrid, Spain, in the Europe region.
How does Synupse make money?
One revenue line is on record: clinical Decision Support System Platform.
Who are Synupse's main competitors?
Direct peers on record are Infermedica, Babylon Health, Ada Health and Mediktor. Emerging players are Qventus, Health Catalyst and LeanTaas. Broad incumbents are K Health, Wolters Kluwer UpToDate and Elsevier ClinicalPath (formerly Via Oncology).
Does Synupse have an API?
No public API is recorded for Synupse.
What industry is Synupse in?
Synupse's product category is Healthcare Clinical Decision Support Software. Its primary akta.pro industry code is HLACAGAM, Utilization Management, Appropriateness Criteria & Prior Authorization CDS, with a secondary code of HLALAJAD, AI Triage & Clinical Decision Support (CDS) Platforms. Its NAICS code is 541519 and its SIC code is 7372.